Linde plc LIN NDXSPX
Basic Materials · Specialty Chemicals · United Kingdom
Linde plc operates as an industrial gas company worldwide. It offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. The company also engages in designing and constructing of turnkey process plants for third-party customers, as well as for the gas businesses in various locations comprising air separation, hydrogen, synthesis, olefin, and natural gas plants. It serves healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics industries. The company operates in the United States, Brazil, Mexico, Canada, Germany, the Unted Kingdom, Eastern Europe, China, Australia, South Korea, And India. Linde plc was founded in 1879 and is based in Woking, the United Kingdom.
READ MORE ›$497.69
+7.88% 1Y
Market & Price
Market Cap
$230.11B
Current Price
$497.69
High / Low (52W)
$517.58 / $388.08
Beta
0.74
Valuation
Stock P/E
33.00
Industry PE
24.80
Forward P/E
25.25
PEG Ratio
2.34
Book Value
$83.37
Price to Book
5.97
P/S
6.64
EV/EBITDA
18.70
Dividend Yield
1.29%
Profitability & Returns
ROCE
13.07%
ROE
18.23%
ROA
7.24%
Profit Margin
20.44%
Op Margin
28.47%
EPS (Latest Qtr)
$3.98
EPS (TTM)
$15.08
Balance Sheet & Liquidity
Debt/Equity
0.66
Quick Ratio
0.62
Current Ratio
0.83
Debt
$26.32B
Total Assets
$86.82B
Current Assets
$13.32B
Working Capital
$-1.87B
Ownership
Promoter Holding
0.25%
Chg in Prom Hold
-
FII / Inst Holding
89.35%
Chg in FII Hold
-0.00%
Financial Snapshot
Enterprise Value
$254.12B
Total Revenue (TTM)
$34.65B
EBITDA
$13.59B
Free Cash Flow
$4.69B
Operating Cash Flow
$10.43B
Shares Outstanding
462.35M
Gross Margin
48.77%
Payout Ratio
40.45%
Growth (CAGR)
Revenue 5Y
0.62%
Profit 5Y
18.48%
Revenue (YoY)
8.20%
Earnings (YoY)
13.40%
PROS
- Excellent profit margin of 20.4%.
- Profit CAGR of 18.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LIN Linde plc NDXSPX | 497.69 | 33.00 | $230.11B | 1.29% | 13.07% | 18.23% | 0.62% | 18.48% |
| 2 | NEM Newmont Corporation SPX | 109.81 | 14.24 | $117.23B | 0.95% | 22.51% | 25.83% | 23.91% | 583.84% |
| 3 | FCX Freeport-McMoRan Inc. SPX | 65.71 | 34.77 | $94.46B | 0.91% | 12.93% | 15.63% | 4.39% | -14.02% |
| 4 | SHW The Sherwin-Williams Company SPX | 303.84 | 29.16 | $74.94B | 1.05% | 20.04% | 60.72% | 2.10% | 8.34% |
| 5 | CRH CRH plc SPX | 108.79 | 20.18 | $72.69B | 1.43% | 11.33% | 15.81% | 4.60% | -1.15% |
| 6 | ECL Ecolab Inc. SPX | 256.00 | 34.59 | $72.05B | 1.14% | 14.89% | 22.43% | 4.26% | 23.88% |
| 7 | APD Air Products and Chemicals, Inc. SPX | 278.62 | 29.33 | $62.04B | 2.60% | -0.62% | 12.35% | -1.77% | -39.16% |
| 8 | NUE Nucor Corporation SPX | 250.00 | 24.80 | $56.94B | 0.90% | 8.80% | 12.29% | -7.84% | -38.80% |
| 9 | CTVA Corteva, Inc. SPX | 78.28 | 42.31 | $52.36B | 0.92% | 6.08% | 5.14% | -0.10% | -1.56% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.73B | 2.83B | 2.92B | 2.95B | 2.98B | 3.04B | 3.01B | 5.80B | 6.94B | 7.20B | 7.00B | 7.08B | 6.74B | 6.38B | 6.86B | 7.24B | 7.58B | 7.67B | 8.21B | 8.46B | 8.80B | 8.19B | 8.20B | 8.15B | 8.10B | 8.27B | 8.36B | 8.11B | 8.49B | 8.62B | 8.76B | 8.78B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.16B | 4.31B | 4.38B | 4.55B | 4.52B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.96B | 4.19B | 4.24B | 4.22B | 4.26B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.73B | 1.85B | 1.89B | 1.86B | 1.88B |
| Operating Income | 567.00M | 606.00M | 632.00M | 639.00M | 653.00M | 689.00M | 669.00M | 3.24B | 609.00M | 669.00M | 1.00B | 655.00M | 733.00M | 591.00M | 969.00M | 1.21B | 1.14B | 1.29B | 1.48B | 589.00M | 1.61B | 1.93B | 2.01B | 2.05B | 2.10B | 2.18B | 2.09B | 2.22B | 2.34B | 2.34B | 2.35B | 2.38B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.15B | 3.35B | 3.38B | 3.23B | 3.44B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.00M | 67.00M | 64.00M | 273.00M | 62.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.18B | 2.35B | 2.36B | 2.01B | 2.43B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 511.00M | 573.00M | 424.00M | 481.00M | 571.00M |
| Net Income | 389.00M | 406.00M | 419.00M | 33.00M | 462.00M | 480.00M | 461.00M | 2.98B | 517.00M | 522.00M | 735.00M | 511.00M | 573.00M | 458.00M | 700.00M | 980.00M | 841.00M | 979.00M | 1.17B | 372.00M | 1.27B | 1.52B | 1.57B | 1.56B | 1.63B | 1.66B | 1.55B | 1.67B | 1.77B | 1.93B | 1.53B | 1.86B |
| Diluted EPS | 1.35 | 1.41 | 1.45 | 0.11 | 1.59 | 1.65 | 1.58 | - | 0.94 | 0.96 | 1.35 | - | 1.07 | 0.87 | 1.32 | 1.86 | 1.60 | 1.88 | 2.30 | 0.74 | 2.54 | 3.06 | 3.19 | 3.19 | 3.35 | 3.44 | 3.22 | 3.51 | 3.73 | 4.09 | 3.26 | 3.98 |
| R&D Expense | - | - | - | - | 24.00M | 24.00M | 23.00M | - | 46.00M | 45.00M | 44.00M | - | 44.00M | 34.00M | 36.00M | 35.00M | 34.00M | 36.00M | 35.00M | 37.00M | 35.00M | 36.00M | 35.00M | 36.00M | 38.00M | 36.00M | 37.00M | 38.00M | 38.00M | 36.00M | - | 38.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.53B | 11.36B | 14.84B | 28.23B | 27.24B | - | 33.36B | 32.85B | 33.01B | 33.99B |
| Cost of Revenue | - | - | - | - | - | - | 19.45B | 17.49B | 17.14B | 17.39B |
| Gross Profit | - | - | - | - | - | - | 13.91B | 15.36B | 15.86B | 16.60B |
| Operating Expenses | - | - | - | - | - | - | 7.45B | 7.26B | 7.27B | 7.34B |
| Operating Income | 2.25B | 2.44B | 5.25B | 2.93B | 3.32B | - | 6.46B | 8.11B | 8.60B | 9.25B |
| EBITDA | - | - | - | - | - | - | 9.96B | 12.22B | 12.84B | 13.12B |
| Interest Expense | - | - | - | - | - | - | 215.00M | 413.00M | 487.00M | 464.00M |
| Pretax Income | - | - | - | - | - | - | 5.54B | 7.99B | 8.57B | 8.90B |
| Tax Provision | - | - | - | - | - | - | 1.43B | 1.81B | 2.00B | 1.99B |
| Net Income | 1.50B | 1.25B | 4.38B | 2.29B | 2.50B | - | 4.15B | 6.20B | 6.57B | 6.90B |
| Diluted EPS | 5.21 | 4.32 | 13.11 | 4.19 | 4.71 | - | 8.23 | 12.59 | 13.62 | 14.61 |
| R&D Expense | 92.00M | 93.00M | 113.00M | 184.00M | 152.00M | 143.00M | 143.00M | 146.00M | 150.00M | 147.00M |
Compounded Sales Growth
| 5 Years: | 0.62% |
| 1 Year: | 8.20% |
Compounded Profit Growth
| 5 Years: | 18.48% |
| 1 Year: | 13.40% |
Stock Price Performance
| 1 Year: | +7.88% |
| 6 Months: | +22.89% |
| 3 Months: | -1.72% |
| 1 Month: | -1.39% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 20.44B | 93.39B | 86.61B | 88.23B | - | 79.66B | 80.81B | 80.15B | 86.82B |
| Current Assets | - | - | - | - | - | - | - | 13.05B | 12.62B | 12.95B | 13.32B |
| Cash & Equivalents | 147.00M | 524.00M | 617.00M | 4.47B | 2.70B | 3.75B | - | 5.44B | 4.66B | 4.85B | 5.06B |
| Inventory | - | - | - | - | - | - | - | 1.98B | 2.12B | 1.95B | 2.06B |
| Receivables | - | - | - | - | - | - | - | 4.56B | 4.72B | 4.62B | 4.97B |
| Total Liabilities | - | - | 13.91B | 36.29B | 34.98B | 38.65B | - | 38.27B | 39.72B | 40.66B | 47.08B |
| Current Liabilities | - | - | 3.31B | 12.96B | 12.16B | 13.74B | - | 16.48B | 15.72B | 14.54B | 15.20B |
| Long Term Debt | - | - | 7.78B | 12.29B | 10.69B | 12.15B | - | 12.20B | 13.40B | 15.34B | 20.68B |
| Total Debt | - | - | - | - | - | - | - | 18.79B | 20.32B | 22.61B | 28.07B |
| Total Equity | - | - | 6.02B | 51.60B | 49.07B | 47.32B | - | 40.03B | 39.72B | 38.09B | 38.24B |
| Shares Outstanding | - | - | - | - | - | - | - | 552.01M | 490.77M | 490.77M | 490.77M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | 7.43B | - | 8.86B | 9.30B | 9.42B | 10.35B |
| Investing Cash Flow | -1.77B | -1.31B | 5.36B | - | -2.99B | - | -3.09B | -4.67B | -4.64B | -5.72B |
| Financing Cash Flow | -659.00M | -1.66B | -5.00B | - | -3.35B | - | -3.09B | -5.40B | -4.36B | -4.55B |
| Capital Expenditure | -1.47B | -1.31B | -1.88B | -3.68B | -3.40B | - | -3.17B | -3.79B | -4.50B | -5.26B |
| Free Cash Flow | - | - | - | - | 4.03B | - | 5.69B | 5.52B | 4.93B | 5.09B |
| Net Change in Cash | - | - | - | - | - | - | 2.69B | -765.00M | 420.00M | 75.00M |
| Share Buybacks | 228.00M | 12.00M | 599.00M | 2.66B | 2.46B | 4.61B | 5.17B | 3.96B | 4.48B | 4.60B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | 41.7% | 46.8% | 48.1% | 48.8% |
| Operating Margin % | 21.3% | 21.5% | 35.4% | 10.4% | 12.2% | - | 19.4% | 24.7% | 26.0% | 27.2% |
| Net Margin % | 14.2% | 11.0% | 29.5% | 8.1% | 9.2% | - | 12.4% | 18.9% | 19.9% | 20.3% |
| ROE % | - | 20.7% | 8.5% | 4.7% | 5.3% | - | 10.4% | 15.6% | 17.2% | 18.0% |
| ROCE % | - | 14.3% | 6.5% | 3.9% | 4.5% | - | 10.2% | 12.5% | 13.1% | 12.9% |
Shareholding Pattern
Insiders
0.25%
Institutions
89.35%
Public Float
89.58%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 7.60% | 36.87M | $18.35B |
| 2 | Vanguard Capital Management LLC | 6.24% | 30.23M | $15.05B |
| 3 | State Street Corporation | 4.05% | 19.63M | $9.77B |
| 4 | Capital Research Global Investors | 3.31% | 16.05M | $7.99B |
| 5 | Vanguard Portfolio Management LLC | 2.53% | 12.29M | $6.12B |
| 6 | Geode Capital Management, LLC | 2.44% | 11.83M | $5.89B |
| 7 | Price (T.Rowe) Associates Inc | 2.03% | 9.85M | $4.90B |
| 8 | FMR, LLC | 1.86% | 9.00M | $4.48B |
| 9 | Morgan Stanley | 1.52% | 7.36M | $3.66B |
| 10 | JPMORGAN CHASE & CO | 1.29% | 6.26M | $3.11B |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LIN
No recent headlines available.